Neonatal chlorpyrifos exposure targets multiple proteins governing the hepatic adenylyl cyclase signaling cascade: Implications for neurotoxicity

Developmental Brain Research

Volumn 121, Issue 1, 2000, Pages 19-27

  Auman, J T ^a   Seidler, F J ^a   Slotkin, T A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adrenoceptor; Adenylyl cyclase; Chlorpyrifos; Development; Glucagon receptor; Liver; Organophosphate insecticides

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; CHLORPYRIFOS; CYCLIC AMP; FLUORIDE; FORSKOLIN; GLUCAGON RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL DIVISION; CELL MATURATION; ENZYME ACTIVITY; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ANIMALS; ANIMALS, NEWBORN; CHLORPYRIFOS; CHOLINESTERASE INHIBITORS; FEMALE; GLUCAGON; ISOPROTERENOL; LIVER; NEUROTOXINS; PREGNANCY; RATS; RECEPTORS, ADRENERGIC, BETA; RECEPTORS, GLUCAGON; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0034636448     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-3806(00)00021-3     Document Type: Article

References (64)

1. Ali M., Cantau B., Clos J. Glycogenolytic responsiveness to glucagon, epinephrine, vasopressin and angiotensin II in the liver of developing hypothyroid rats. A comparative study of in vitro hormonal binding and in vivo biological response. J. Dev. Physiol. 11:1989;360-367.
2. Bagchi D., Bagchi M., Hassoun E.A., Stohs S.J. In vitro and in vivo generation of reactive oxygen species, DNA damage and lactate dehydrogenase leakage by selected pesticides. Toxicology. 104:1995;129-140.
3. Bagchi D., Bhattacharya G., Stohs S.J. In vitro and in vivo induction of heat shock (stress) protein (Hsp) gene expression by selected pesticides. Toxicology. 112:1996;57-68.
4. Breslin W.J., Liberacki A.B., Dittenber D.A., Quast J.F. Evaluation of the developmental and reproductive toxicity of chlorpyrifos in the rat. Fund. Appl. Toxicol. 29:1996;119-130.
5. Campbell C.G., Seidler F.J., Slotkin T.A. Chlorpyrifos interferes with cell development in rat brain regions. Brain Res. Bull. 43:1997;179-189.
6. Chanda S.M., Mortensen S.R., Moser V.C., Padilla S. Tissue-specific effects of chlorpyrifos on carboxylesterase and cholinesterase activity in adult rats: an in vitro and in vivo comparison. Fund. Appl. Toxicol. 38:1997;148-157.
7. Chaudhry A., Granneman J.G. Developmental changes in adenylyl cyclase and GTP binding proteins in brown fat. Amer. J. Physiol. 261:1991;R403-R411.
8. Chaudhry A., Muffler L.A., Yao R.H., Granneman J.G. Perinatal expression of adenylyl cyclase subtypes in rat brown adipose tissue. Amer. J. Physiol. 270:1996;R755-R760.
9. Claycomb W.C. Biochemical aspects of cardiac muscle differentiation. J. Biol. Chem. 251:1976;6082-6089.
10. Costa L.G., Li W.F., Richter R.J., Shih D.M., Lusis A., Furlong C.E. The role of paraoxonase (PON1) is the detoxication of organophosphates and its human polymorphism. Chem. Biol. Inter. 120:1999;429-438.
11. Crumpton T.L., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: effects on nuclear transcription factors involved in cell differentiation. Toxicologist. 48:1999;253.
12. Dam K., Garcia S.J., Seidler F.J., Slotkin T.A. Neonatal chlorpyrifos exposure alters synaptic development and neuronal activity in cholinergic and catecholaminergic pathways. Dev. Brain Res. 116:1999;9-20.
13. Dam K., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: delayed targeting of DNA synthesis after repeated administration. Dev. Brain Res. 108:1998;39-45.
14. Duée P.H., Pégorier J.P., El Manoubi L., Ferré P., Bois-Joyeux B., Girard J. Development of gluconeogenesis from different substrates in newborn rabbit hepatocytes. J. Dev. Physiol. 8:1986;387-394.
15. Fattal O., Vandop C., Chen F., Chang J.T., Zoltan T.B., Wetzel G.T., Klitzner T.S. Steady-state mRNA levels of G protein subunits in developing rabbit myocardium. Biochem. Mol. Med. 56:1995;108-114.
16. Fenske R.A., Black K.G., Elkner K.P., Lee C., Methner M.M., Soto R. Potential exposure and health risks of infants following indoor residential pesticide applications. Am. J. Publ. Health. 80:1990;689-693.
17. Guidotti A. Adenosine 3′,5′-monophosphate concentrations and isoproterenol-induced synthesis of deoxyribonucleic acid in mouse parotid gland. Mol. Pharmacol. 8:1972;521-530.
18. Gurunathan S., Robson M., Freeman N., Buckley B., Roy A., Meyer R., Bukowski J., Lioy P.J. Accumulation of chlorpyrifos on residential surfaces and toys accessible to children. Environ. Health Persp. 106:1998;9-16.
19. Haley R.W., Billecke S., La Du B.N. Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol. Appl. Pharmacol. 157:1999;227-233.
20. Huff R.A., Abou-Donia M.B. In vitro effect of chlorpyrifos oxon on muscarinic receptors and adenylate cyclase. Neurotoxicology. 16:1995;281-290.
21. Huff R.A., Corcoran J.J., Anderson J.K., Abou-Donia M.B. Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J. Pharmacol. Exp. Ther. 269:1994;329-335.
22. Huff R.A., Seidler F.J., Slotkin T.A. Glucocorticoids regulate the ontogenetic transition of adrenergic receptor subtypes in rat liver. Life Sci. 48:1991;1059-1066.
23. Hultgårdh-Nilsson A., Querol-Ferrer V., Jonzon B., Krondahl U., Nilsson J. Cyclic AMP, early response gene expression, and DNA synthesis in rat smooth muscle cells. Exp. Cell Res. 214:1994;297-302.
24. Hunter D.L., Lassiter T.L., Chanda S.M., Barone S., Padilla S. Pharmacokinetics of chlorpyrifos and its metabolites in maternal and fetal brain and liver tissue following gestational exposure. Toxicologist. 42:1998;157-158.
25. Hunter D.L., Lassiter T.L., Padilla S. Gestational exposure to chlorpyrifos: comparative distribution of trichloropyridinol in the fetus and dam. Toxicol. Appl. Pharmacol. 158:1999;16-23.
26. Hurley J.H. Structure, mechanism, and regulation of mammalian adenylyl cyclase. J. Biol. Chem. 274:1999;7599-7602.
27. Johnson D.E., Seidler F.J., Slotkin T.A. Early biochemical detection of delayed neurotoxicity resulting from developmental exposure to chlorpyrifos. Brain Res. Bull. 45:1998;143-147.
28. Kaplan J.G., Kessler J., Rosenberg N., Pack D. Sensory disturbances associated with Dursban (chlorpyrifos) exposure. Neurology. 43:1993;2193-2196.
29. Katz M.S., Boland S.R., Schmidt S.J. Developmental changes of β-adrenergic receptor-linked adenylate cyclase of rat liver. Am. J. Physiol. 248:1985;E712-E718.
30. Kohrman A.F. Patterns of development of adenyl cyclase activity and norepinephrine responsiveness in the rat. Pediatr. Res. 7:1973;575-581.
31. Lagercrantz H., Slotkin T.A. The 'stress' of being born. Sci. Am. 254:1986;100-107.
32. Landrigan P.J., Claudio L., Markowitz S.B., Berkowitz G.S., Brenner B.L., Romero H., Wetmur J.G., Matte T.D., Gore A.C., Godbold J.H., Wolff M.S. Pesticides and inner-city children: exposures, risks, and prevention. Environ. Hlth. Perspect. 107:1999;431-437.
33. Lassiter T.L., Padilla S., Mortensen S.R., Chanda S.M., Moser V.C., Barone S. Gestational exposure to chlorpyrifos: apparent protection of the fetus? Toxicol. Appl. Pharmacol. 152:1998;56-65.
34. Lautt W.W. Autonomic control of liver glycogen metabolism. Med. Hypoth. 5:1979;1287-1296.
35. Li W.W., Casida J.E. Organophosphorus neuropathy target esterase inhibitors selectively block outgrowth of neurite-like and cell processes in cultured cells. Toxicol. Lett. 98:1998;139-146.
36. Limbird L.E., Macmillan S.T. Mn-uncoupling of the catecholamine sensitive adenylate cyclase system of rat reticulocytes. Biochim. Biophys. Acta. 677:1981;408-416.
37. Lu C.S., Fenske R.A. Dermal transfer of chlorpyrifos residues from residential surfaces: comparison of hand press, hand drag, wipe, and polyurethane foam roller measurements after broadcast and aerosol pesticide applications. Environ. Hlth. Perspect. 107:1999;463-467.
38. McMillian M.K., Schanberg S.M., Kuhn C.M. Ontogeny of rat hepatic adrenoceptors. J. Pharmacol. Exp. Ther. 227:1983;181-186.
39. Mileson B.E., Chambers J.E., Chen W.L., Dettbarn W., Ehrich M., Eldefrawi A.T., Gaylor D.W., Hamernik K., Hodgson E., Karczmar A.G., Padilla S., Pope C.N., Richardson R.J., Saunders D.R., Sheets L.P., Sultatos L.G., Wallace K.B. Common mechanism of toxicity: a case study of organophosphorus pesticides. Toxicol. Sci. 41:1998;8-20.
40. 2 adrenergic receptors. J. Biol. Chem. 258:1983;5103-5109.
41. Moser V.C., Chanda S.M., Mortensen S.R., Padilla S. Age- and gender-related differences in sensitivity to chlorpyrifos in the rat reflect developmental profiles of esterase activities. Toxicol. Sci. 46:1998;211-222.
42. Moser V.C., Padilla S. Age- and gender-related differences in the time course of behavioral and biochemical effects produced by oral chlorpyrifos in rats. Toxicol. Appl. Pharmacol. 149:1998;107-119.
43. ®. Vet. Hum. Toxicol. 34:1992;498-501.
44. Navarro H.A., Kudlacz E.M., Slotkin T.A. Control of adenylate cyclase activity in developing rat heart and liver: effects of prenatal exposure to terbutaline or dexamethasone. Biol. Neonate. 60:1991;127-136.
45. Nostrandt A.C., Padilla S., Moser V.C. The relationship of oral chlorpyrifos effects on behavior, cholinesterase inhibition, and muscarinic receptor density in rat. Pharmacol. Biochem. Behav. 58:1997;15-23.
46. Pope C.N. Organophosphorus pesticides: do they all have the same mechanism of toxicity? J. Toxicol. Environm. Hlth. 2:1999;161-181.
47. Pope C.N., Chakraborti T.K. Dose-related inhibition of brain and plasma cholinesterase in neonatal and adult rats following sublethal organophosphate exposures. Toxicology. 73:1992;35-43.
48. Pope C.N., Chakraborti T.K., Chapman M.L., Farrar J.D., Arthun D. Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. Toxicology. 68:1991;51-61.
49. Premont R.T., Matsuoka I., Mattei M.G., Pouille Y., Defer N., Hanoune J. Identification and characterization of a widely expressed form of adenylyl cyclase. J. Biol. Chem. 271:1996;13900-13907.
50. Richardson R.J., Moore T.B., Kayyali U.S., Randall J.C. Chlorpyrifos: assessment of potential for delayed neurotoxicity by repeated dosing in adult hens with monitoring of brain acetylcholinesterase, brain and lymphocyte neurotoxic esterase and plasma butyrylcholinesterase activities. Fund. Appl. Toxicol. 21:1993;89-96.
51. Rius R.A., Streaty R.A., Loh Y.P., Klee W.A. Developmental expression of G proteins that differentially modulate adenylyl cyclase activity in mouse brain. FEBS Lett. 288:1991;51-54.
52. Roy T.S., Andrews J.E., Seidler F.J., Slotkin T.A. Chlorpyrifos elicits mitotic abnormalities and apoptosis in neuroepithelium of cultured rat embryos. Teratology. 58:1998;62-68.
53. Scarpace P.J., Matheny M., Tumer N. Myocardial adenylyl cyclase type V and VI mRNA: differential regulation with age. J. Cardiovasc. Pharmacol. 27:1996;86-90.
54. Seamon K.B., Daly J.W. Forskolin: its biological and chemical properties. Adv. Cyclic Nucleotide Protein Phosphorylation Res. 20:1986;1-150.
55. Sherman J.D. Chlorpyrifos (Dursban)-associated birth defects: report of four cases. Arch. Environm. Health. 51:1996;5-8.
56. Slotkin T.A. Developmental cholinotoxicants: nicotine and chlorpyrifos. Environ. Hlth. Perspect. 107:1999;71-80.
57. Song X., Seidler F.J., Saleh J.L., Zhang J., Padilla S., Slotkin T.A. Cellular mechanisms for developmental toxicity of chlorpyrifos: targeting the adenylyl cyclase signaling cascade. Toxicol. Appl. Pharmacol. 145:1997;158-174.
58. Song X., Violin J.D., Seidler F.J., Slotkin T.A. Modeling the developmental neurotoxicity of chlorpyrifos in vitro: macromolecule synthesis in PC12 cells. Toxicol. Appl. Pharmacol. 151:1998;182-191.
59. Van Wijk R., Wicks W.D., Bevers M.M., Van Rijn J. Rapid arrest of DNA synthesis by N6,O2′-dibutyryl cyclic adenosine 3′,5′-monophosphate in cultured hepatoma cells. Cancer Res. 33:1973;1331-1338.
60. Ward T.R., Mundy W.R. Organophosphorus compounds preferentially affect second messenger systems coupled to M2/M4 receptors in rat frontal cortex. Brain Res. Bull. 39:1996;49-55.
61. Whitney K.D., Seidler F.J., Slotkin T.A. Developmental neurotoxicity of chlorpyrifos: cellular mechanisms. Toxicol. Appl. Pharmacol. 134:1995;53-62.
62. Zeiders J.L., Seidler F.J., Iaccarino G., Koch W.J., Slotkin T.A. Ontogeny of cardiac β-adrenoceptor desensitization mechanisms: agonist treatment enhances receptor/G-protein transduction rather than eliciting uncoupling. J. Mol. Cell. Cardiol. 31:1999;413-423.
63. Zeiders J.L., Seidler F.J., Slotkin T.A. Ontogeny of regulatory mechanisms for β-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. J. Mol. Cell. Cardiol. 29:1997;603-615.
64. Zeiders J.L., Seidler F.J., Slotkin T.A. Agonist-induced sensitization of β-adrenoceptor signaling in neonatal rat heart: expression and catalytic activity of adenylyl cylcase. J. Pharmacol. Exp. Ther. 291:1999;503-510.